1. Home
  2. SPRU vs ITRM Comparison

SPRU vs ITRM Comparison

Compare SPRU & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRU
  • ITRM
  • Stock Information
  • Founded
  • SPRU 2008
  • ITRM 2015
  • Country
  • SPRU United States
  • ITRM Ireland
  • Employees
  • SPRU N/A
  • ITRM N/A
  • Industry
  • SPRU Auto Parts:O.E.M.
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPRU Consumer Discretionary
  • ITRM Health Care
  • Exchange
  • SPRU Nasdaq
  • ITRM Nasdaq
  • Market Cap
  • SPRU 34.9M
  • ITRM 40.0M
  • IPO Year
  • SPRU N/A
  • ITRM 2018
  • Fundamental
  • Price
  • SPRU $1.76
  • ITRM $0.67
  • Analyst Decision
  • SPRU
  • ITRM Strong Buy
  • Analyst Count
  • SPRU 0
  • ITRM 1
  • Target Price
  • SPRU N/A
  • ITRM $9.00
  • AVG Volume (30 Days)
  • SPRU 105.2K
  • ITRM 682.8K
  • Earning Date
  • SPRU 11-12-2025
  • ITRM 11-13-2025
  • Dividend Yield
  • SPRU N/A
  • ITRM N/A
  • EPS Growth
  • SPRU N/A
  • ITRM N/A
  • EPS
  • SPRU N/A
  • ITRM N/A
  • Revenue
  • SPRU $98,396,000.00
  • ITRM N/A
  • Revenue This Year
  • SPRU $2.12
  • ITRM N/A
  • Revenue Next Year
  • SPRU N/A
  • ITRM $482.25
  • P/E Ratio
  • SPRU N/A
  • ITRM N/A
  • Revenue Growth
  • SPRU 23.43
  • ITRM N/A
  • 52 Week Low
  • SPRU $1.13
  • ITRM $0.61
  • 52 Week High
  • SPRU $3.25
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • SPRU 65.52
  • ITRM 41.36
  • Support Level
  • SPRU $1.47
  • ITRM $0.66
  • Resistance Level
  • SPRU $1.71
  • ITRM $0.76
  • Average True Range (ATR)
  • SPRU 0.09
  • ITRM 0.05
  • MACD
  • SPRU 0.03
  • ITRM 0.01
  • Stochastic Oscillator
  • SPRU 80.49
  • ITRM 41.04

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: